miR-151a has been shown to function synergistically with its host gene, FAK, which is overexpressed as a result of gene amplification in many types of tumors, including lung cancer, and associated with poor prognosis.16, 17 These findings warrant studies of a potential role for miR-151a in NSCLC pathology. Here, PTK2 is linked to lung cancer.